Clopidogrel Versus Cilostazol on Vessels

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.

Also called NCT06402747

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06402747
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06402747. Randomized; no masking; primary purpose prevention. Start 2024-04-16 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clopidogrel Versus Cilostazol on Vessels
Condition
Atherosclerosis
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Cilostazol
Lead sponsor
Seoul National University Bundang Hospital (class: other)
Collaborator
Samjin Pharmaceutical Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct06402747
Content hash
e6b89e9da1dbe847bef8d59a5a2755c73b8b80407b67f644bfc23ddf87caa5ac